31 Mar 2025 Avacta Provides Business Update for the First Quarter of 2025 Outlining Progress Against Strategic Objectives Investors
26 Mar 2025 Avacta Therapeutics Announces Presentations at 2025 AACR Annual Meeting Investors | Therapeutics
10 Mar 2025 Avacta Therapeutics to Present at the 2025 Leerink Global Healthcare Conference Investors
07 Mar 2025 Avacta Announces Promising Early Efficacy and Safety Data for AVA6000 in the Phase 1a Dose Escalation and Ongoing Enrollment in the Phase 1b Expansion Cohorts Investors | Therapeutics
07 Mar 2025 Avacta Announces Agreement to Sell Launch Diagnostics and a Corporate Update Diagnostics | Investors
16 Jan 2025 Avacta Announces Positive New Data from the AVA6000 Phase 1 trial Demonstrating Clinically Meaningful Tumor Shrinkage in Patients with Salivary Gland Cancers Investors | Therapeutics